Markus Hartenbach - Concepedia

Author

Markus Hartenbach

Medical University of Vienna ORCID

Also Known As

Hartenbach, Markus, M Hartenbach, M. Hartenbach, Markus Hartenbach

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Ludwig Boltzmann Institute Applied Diagnostics Center For Biomarker Research In Medicine Cornell University The University of Texas Southwestern Medical Center

About

Markus Hartenbach is an author at Medical University of Vienna specializing in positron emission tomography, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	182
2	Health Sciences	2	2	167
3	Neuroscience	2	2	105
4	Social Sciences	1	1	15
5	Pharmacology	1	1	15

Markus Hartenbach

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT Matthias Eiber, Ken Herrmann, Jérémie Calais, Journal of Nuclear Medicine	2017	574
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer Bernhard Grubmüller, Daniela Senn, Gero Kramer, European Journal of Nuclear Medicine and Molecular Imaging	2018	149
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact Bernhard Grubmüller, Pascal Baltzer, Sabrina Hartenbach, Clinical Cancer Research	2018	146
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study Wolfgang P. Fendler, Jérémie Calais, Martin Allen-Auerbach, Journal of Nuclear Medicine	2017	138
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI László Papp, Clemens P. Spielvogel, Bernhard Grubmüller, European Journal of Nuclear Medicine and Molecular Imaging	2020	135
68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making Bernhard Grubmüller, Pascal Baltzer, David D‘Andrea, European Journal of Nuclear Medicine and Molecular Imaging	2017	118
Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI Lucas Rischka, Gregor Gryglewski, Sarah Pfaff, NeuroImage Positron Emission TomographyMedical ImagingTask DurationsPet-mriBiomedical Imaging	2018	90
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy Vera Graute, Nathalie Jansen, Christopher Übleis, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyTotal ProstatectomyUrologySurgical OncologyOncologic Imaging	2011	77
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks Sazan Rasul, Marcus Hacker, Elisabeth Kretschmer‐Chott, European Journal of Nuclear Medicine and Molecular Imaging	2019	70
Response assessment using [<sup>68</sup>Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer Bernhard Grubmüller, Sazan Rasul, Pascal Baltzer, The Prostate	2019	68

Page 1